PTC Therapeutics Inc (PTCT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché PTCT Giù? Forum Previsione

Perché le azioni PTC Therapeutics Inc (PTCT) sono in ribasso?

Abbiamo notato un calo di 6.17% nelle azioni di PTC Therapeutics Inc (PTCT) durante la sessione di negoziazione di 2024-03-14. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-10-27:

Shares of PTC Therapeutics (PTCT) dropped by 22.71% from $23.95 to $18.51 in the trading on Friday, October 27, 2023. The reason why PTCT stock down is due to a change in its regulatory submission plan. Originally, PTC Therapeutics had planned to seek FDA approval in the fourth quarter of 2023. However, the FDA now requires a 26-week nonclinical mouse study before authorization. As a result, PTC Therapeutics has altered its submission pathway from 505(b)(2) to 505(b)(1), which necessitates the collection of additional data. This regulatory change has impacted investor sentiment, leading to the significant drop in PTCT's stock price.

2023-09-15:

European regulators rejected full approval for PTC Therapeutics' Duchenne muscular dystrophy treatment, Translarna, causing a 29.8% drop in PTC stock. The decision came due to insufficient evidence, and PTC plans to seek reexamination from the European Commission.

https://www.investors.com/news/technology/ptc-stock-crashes-after-european-regulators-reject-its-muscular-dystrophy-drug/?src=A00220